Olema Pharmaceuticals (OLMA) Insider Trading & Ownership $11.83 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Olema Pharmaceuticals (NASDAQ:OLMA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.40%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$17.85 MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$39.33 M Get OLMA Insider Trade Alerts Want to know when executives and insiders are buying or selling Olema Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OLMA Insider Buying and Selling by Quarter Ad Deal MakerThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.Learn more about this much-needed advancement and investment opportunity here. Olema Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/1/2024Biocapital Advisors L ParadigmMajor ShareholderSell2,400,000$14.91$35,784,000.00 7/29/2024Cyrus HarmonDirectorSell4,066$15.58$63,348.28 7/11/2024Cyrus HarmonDirectorSell5,000$12.26$61,300.00 6/28/2024Cyrus HarmonDirectorSell20,000$10.77$215,400.00 6/3/2024Cyrus HarmonDirectorSell5,000$10.93$54,650.00 5/31/2024Cyrus HarmonDirectorSell15,000$9.41$141,150.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/6/2024Cyrus HarmonDirectorSell5,000$10.92$54,600.00 4/30/2024Cyrus HarmonDirectorSell15,000$9.51$142,650.00 3/28/2024Cyrus HarmonDirectorSell20,000$10.97$219,400.00 2/29/2024Cyrus HarmonDirectorSell25,000$12.41$310,250.00 1/31/2024Cyrus HarmonDirectorSell25,000$12.23$305,750.00 12/6/2023Biocapital Advisors L ParadigmMajor ShareholderBuy100,000$11.60$1,160,000.00 12/5/2023G. Walmsley GrahamDirectorBuy131,870$14.19$1,871,235.30 11/30/2023Cyrus HarmonDirectorSell25,000$12.57$314,250.00 11/21/2023Cyrus HarmonDirectorSell4,192$14.86$62,293.12 11/21/2023Naseem ZojwallaInsiderSell7,461$14.84$110,721.24 11/21/2023Sean BohenCEOSell29,293$14.88$435,879.84 11/8/2023David C MylesInsiderSell200$17.61$3,522.00 11/3/2023David C MylesInsiderSell541$17.51$9,472.91 11/2/2023Cyrus HarmonDirectorSell5,000$15.64$78,200.00 11/1/2023David C MylesInsiderSell6,668$15.02$100,153.36 10/31/2023Cyrus HarmonDirectorSell25,000$12.05$301,250.00 9/29/2023Cyrus HarmonDirectorSell25,000$12.41$310,250.00 9/19/2023David C MylesInsiderSell20,000$12.67$253,400.00 9/12/2023Bvf Partners L P/IlDirectorBuy1,505,932$9.84$14,818,370.88 (Data available from 1/1/2013 forward) OLMA Insider Trading Activity - Frequently Asked Questions Who is on Olema Pharmaceuticals's Insider Roster? The list of insiders at Olema Pharmaceuticals includes Biocapital Advisors L Paradigm, Bvf Partners L P/Il, Cyrus Harmon, David C Myles, G. Walmsley Graham, Kinney Horn, Naseem Zojwalla, and Sean Bohen. Learn more on insiders at OLMA. What percentage of Olema Pharmaceuticals stock is owned by insiders? 19.40% of Olema Pharmaceuticals stock is owned by insiders. Learn more on OLMA's insider holdings. Which Olema Pharmaceuticals insiders have been buying company stock? The following insiders have purchased OLMA shares in the last 24 months: Biocapital Advisors L Paradigm ($1,160,000.00), Bvf Partners L P/Il ($14,818,370.88), and G. Walmsley Graham ($1,871,235.30). How much insider buying is happening at Olema Pharmaceuticals? Insiders have purchased a total of 1,737,802 OLMA shares in the last 24 months for a total of $17,849,606.18 bought. Which Olema Pharmaceuticals insiders have been selling company stock? The following insiders have sold OLMA shares in the last 24 months: Biocapital Advisors L Paradigm ($35,784,000.00), Cyrus Harmon ($2,984,541.40), David C Myles ($366,548.27), Naseem Zojwalla ($110,721.24), and Sean Bohen ($435,879.84). How much insider selling is happening at Olema Pharmaceuticals? Insiders have sold a total of 2,727,421 Olema Pharmaceuticals shares in the last 24 months for a total of $39,681,690.75 sold. More Insider Trading Tools from MarketBeat Related Companies: AGIO Insider Selling AMRX Insider Selling ACAD Insider Selling PTGX Insider Selling CPRX Insider Selling AMPH Insider Selling JANX Insider Selling MRVI Insider Selling VRNA Insider Selling BHC Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock3 Small Cap Stocks Insiders Are Actively BuyingTop 2 High-Yield Stocks That Insiders Are BuyingInsider Selling: When It Matters and When It Doesn't This page (NASDAQ:OLMA) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Olema Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Olema Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.